Trulieve Cannabis Corp. (TCNNF) Financials
TCNNF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 2.1 billion | 1.3 billion |
| March 31, 2026 | 2.8 billion | 1.6 billion |
| Dec. 31, 2025 | 2.7 billion | 1.6 billion |
| Sept. 30, 2025 | 2.9 billion | 1.8 billion |
TCNNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 32.1 million | 6.9 million |
| March 31, 2026 | 42.2 million | 4.1 million |
| Dec. 31, 2025 | 56.7 million | 4.0 million |
| Sept. 30, 2025 | 69.1 million | 5.8 million |
TCNNF Net Income
No data available :(
TCNNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 325.4 million | 235.0 million | 287.8 million |
| March 31, 2026 | 352.9 million | 286.7 million | 339.8 million |
| Dec. 31, 2025 | 255.1 million | 334.9 million | 331.4 million |
| Sept. 30, 2025 | 449.2 million | 473.8 million | 335.5 million |
TCNNF Shares Outstanding
TCNNF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 21.0 million | - | 101.8 million | - |
| March 31, 2026 | 13.5 million | - | 104.9 million | - |
| Dec. 31, 2025 | 3.4 million | - | 126.3 million | - |
| Sept. 30, 2025 | 7.7 million | - | 99.0 million | - |
TCNNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 271.0 million | 108.7 million |
| March 31, 2026 | 282.8 million | 144.4 million |
| Dec. 31, 2025 | 297.7 million | 149.7 million |
| Sept. 30, 2025 | 288.2 million | 118.3 million |
TCNNF Revenue by Segment
Graph available only for paid members. Upgrade to see it.
TCNNF
Price: $12.25
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.62 USD
P/E Ratio: -9.92
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.4 million
Market Capitalization: 2.4 billion